Fiacitabine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H11FIN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4058H365ZB, chemically known as 2(1h)-pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo- but generally known as fiacitabine, which bears US NIH Compound Identifier 50312. European Medicines Agency schedules Fiacitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07621MIG. The term FIACITABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). FIACITABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fiacitabine under HS 29349990 and SITC 51579. As of Q4 2014, FIACITABINE remains the US FDA Preferred Term for this commodity. Fiacitabine bears US NLM identifiers UMLS ID C0045211 and NCI Concept Code C73202. SMILES: IC1CN(C2OC(C(O)C2F)CO)C(=O)NC1N.